Remarks

• These recommendations have been adapted and integrated from the 2021 WHO consolidated guidelines on tuberculosis Module 2: Screening – Systematic screening for tuberculosis disease (43) where Recommendations 3a and 3b were considered conditional recommendations based on low and very low-certainty evidence, respectively, and Recommendation 3c was considered a strong recommendation based on moderate-certainty evidence.
• Related recommendations from this guideline include the following.
• In high-prevalence settings, systematic screening for active tuberculosis should be considered for pregnant women as part of antenatal care as per the 2016 WHO recommendations on antenatal care for a positive pregnancy experience (16).
• Systematic screening for TB disease may be conducted among women in the postpartum period in subpopulations with structural risk factors for TB. These include urban poor communities, homeless communities, communities in remote or isolated areas, Indigenous populations, migrants, refugees, internally displaced persons and other priority groups with limited access to health care.
• Any newborn whose mother has tested positive or who has had close contact with someone with TB disease should be screened for TB with a symptom screen and/or chest radiograph as part of active contact tracing.